Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chaitchik

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Oncology|November 1, 1996
Prognostic importance of advanced age in aggressive non-Hodgkin's malignant lymphomaF Kovner, O Merimsky, M Inbar, et al.
American Journal of Clinical Oncology|August 1, 1996
Malignant melanoma of the head and neck. Clinical and immunological considerationsO Merimsky, P Fishman, I Feldman, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1988
An evaluation of the SCM test for the diagnosis of cancer of the breastS Chaitchik, M Deutsch, O Asher, et al.
Oncology Reports|May 20, 2011
Potential for anatomic localization in colorectal cancer using the SCM testO Merimsky, M Deutsch, I Ron, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1993
Effect of allogeneic tumor cells, interleukin-2 and interleukin-6, on the growth of subcutaneous syngeneic tumorsA Eisenthal, Y Skornick, O Merimsky, et al.
Gynecologic and Obstetric Investigation|January 1, 1983
Survival data of Israeli Jewish patients with squamous cell carcinoma of the cervix treated by irradiationJ Menczer, M Atlas, A Werner, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1994
A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-alpha 2a in patients with advanced malignant melanomaI G Ron, Y Mordish, A Eisenthal, et al.
Journal of Neuro-Oncology|April 3, 1998
Primary intramedullary spinal melanoma: diagnostic and treatment problemsK Salame, O Merimsky, J Yosipov, et al.
American Journal of Clinical Oncology|October 1, 1987
Conventional fractionation radiotherapy combined with 5-fluorouracil for metastatic malignant melanomaJ M Klausner, M Gutman, R R Rozin, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1996
Anti-tyrosinase antibodies in malignant melanomaO Merimsky, E Baharav, Y Shoenfeld, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Oncology|November 1, 1996
Prognostic importance of advanced age in aggressive non-Hodgkin's malignant lymphomaF Kovner, O Merimsky, M Inbar, et al.
American Journal of Clinical Oncology|August 1, 1996
Malignant melanoma of the head and neck. Clinical and immunological considerationsO Merimsky, P Fishman, I Feldman, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1988
An evaluation of the SCM test for the diagnosis of cancer of the breastS Chaitchik, M Deutsch, O Asher, et al.
Oncology Reports|May 20, 2011
Potential for anatomic localization in colorectal cancer using the SCM testO Merimsky, M Deutsch, I Ron, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1993
Effect of allogeneic tumor cells, interleukin-2 and interleukin-6, on the growth of subcutaneous syngeneic tumorsA Eisenthal, Y Skornick, O Merimsky, et al.
Gynecologic and Obstetric Investigation|January 1, 1983
Survival data of Israeli Jewish patients with squamous cell carcinoma of the cervix treated by irradiationJ Menczer, M Atlas, A Werner, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1994
A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-alpha 2a in patients with advanced malignant melanomaI G Ron, Y Mordish, A Eisenthal, et al.
Journal of Neuro-Oncology|April 3, 1998
Primary intramedullary spinal melanoma: diagnostic and treatment problemsK Salame, O Merimsky, J Yosipov, et al.
American Journal of Clinical Oncology|October 1, 1987
Conventional fractionation radiotherapy combined with 5-fluorouracil for metastatic malignant melanomaJ M Klausner, M Gutman, R R Rozin, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1996
Anti-tyrosinase antibodies in malignant melanomaO Merimsky, E Baharav, Y Shoenfeld, et al.
Pageof 12